Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free
- BOND RX™ Validated
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal XRCC4 antibody. Carrier free. Suitable for IHC-P, IP, WB and reacts with Human samples.
View Alternative Names
DNA repair protein XRCC4, hXRCC4, X-ray repair cross-complementing protein 4, XRCC4
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free (AB317698)
This data was developed using ab317697, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling XRCC4 with ab317697 at 1/500 (1.032 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining in human tonsil.
The section was incubated with ab317697 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free (AB317698)
This data was developed using ab317697, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human endometrioid carcinoma tissue labeling XRCC4 with ab317697 at 1/500 (1.032 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining in human endometrioid carcinoma.
The section was incubated with ab317697 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free (AB317698)
This data was developed using ab317697, the same antibody clone in a different buffer formulation.
Immunohistochemical analysis of paraffin-embedded Human breast tissue labeling XRCC4 with ab317697 at 1/500 (1.032 ug/ml) dilution, followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Positive staining in human breast.
The section was incubated with ab317697 for 30 mins at room temperature.
The immunostaining was performed on a Leica Biosystems BOND® RX instrument
Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
- IP
Supplier Data
Immunoprecipitation - Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free (AB317698)
This data was developed using ab317697, the same antibody clone in a different buffer formulation.
XRCC4 was immunoprecipitated from 0.35 mg HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate with ab317697 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab317697 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 2 : ab317697 IP in HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab317697 in HeLa whole cell lysate
All lanes:
Immunoprecipitation - Anti-XRCC4 antibody [EPR28958-63] (<a href='/en-us/products/primary-antibodies/xrcc4-antibody-epr28958-63-ab317697'>ab317697</a>) at 1/30 dilution
All lanes:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
false
Exposure time: 50s
- WB
Supplier Data
Western blot - Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free (AB317698)
This data was developed using ab317697, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-XRCC4 antibody [EPR28958-63] (<a href='/en-us/products/primary-antibodies/xrcc4-antibody-epr28958-63-ab317697'>ab317697</a>) at 1/1000 dilution
All lanes:
Human tonsil tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 35 kDa,55 kDa
false
Exposure time: 70s
- WB
Supplier Data
Western blot - Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free (AB317698)
This data was developed using ab317697, the same antibody clone in a different buffer formulation.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-XRCC4 antibody [EPR28958-63] (<a href='/en-us/products/primary-antibodies/xrcc4-antibody-epr28958-63-ab317697'>ab317697</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervical adenocarcinoma epithelial cell) transfected with scrambled siRNA control whole cell lysate at 20 µg
Lane 2:
HeLa transfected with siRNA specifically targeti XRCC4 whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 35 kDa,55 kDa,124 kDa
false
Exposure time: 48s
- WB
Supplier Data
Western blot - Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free (AB317698)
This data was developed using ab317697, the same antibody clone in a different buffer formulation.
The expression of caspase cleaved XRCC4 is upregulated upon induction of apoptosis (PMID : 33725486).
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-XRCC4 antibody [EPR28958-63] (<a href='/en-us/products/primary-antibodies/xrcc4-antibody-epr28958-63-ab317697'>ab317697</a>) at 1/1000 dilution
Lane 1:
Untreated heLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with 2uM staurosporine for 3h whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 35 kDa,55 kDa,124 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-XRCC4 antibody [EPR28958-63] - BSA and Azide free (AB317698)
This data was developed using ab317697, the same antibody clone in a different buffer formulation.
In Lane 1-Lane 4, lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
All lanes:
Western blot - Anti-XRCC4 antibody [EPR28958-63] (<a href='/en-us/products/primary-antibodies/xrcc4-antibody-epr28958-63-ab317697'>ab317697</a>) at 1/1000 dilution
Lanes 1 and 6:
HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lanes 2 and 5:
HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lanes 3 and 7:
293T (human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 4:
T-47D (human ductal breast epithelial tumor epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 55 kDa
false
Exposure time: 15s
Related conjugates and formulations (1)
-
Anti-XRCC4 antibody [EPR28958-63]
Reactivity data
Product details
ab317698 is the carrier-free version of ab317697.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
XRCC4 plays a pivotal role in maintaining genetic stability. It is a vital component of the DNA repair machinery and functions as part of a complex with DNA ligase IV. This complex ensures the appropriate joining of DNA ends which is critical for cell survival and prevention of chromosomal aberrations. Without XRCC4 cells would face higher mutational rates and increased genomic instability leading to cellular dysfunction and disease progression.
Pathways
XRCC4 is integral to the non-homologous end joining pathway a major DNA double-strand break repair mechanism in human cells. It interacts with DNA-dependent protein kinase (DNA-PK) and DNA ligase IV during the repair process. Within the NHEJ pathway XRCC4 collaborates closely with DNA ligase IV to seal DNA breaks effectively. It also engages with other proteins such as Ku70/Ku80 to ensure proper coordination of DNA repair activities within the cell.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com